Dominant Type of Arrhythmia Mandating Cardiac Radiofrequency Ablation Over the Course of 12 Months
Abstract:
Radiofrequency ablation proves to be a highly efficient and secure method for managing cardiac arrhythmias. Ablation, widely recognized as the primary approach for treating specific arrhythmias, has overtaken the use of pharmacological interventions involving antiarrhythmic drugs. This study follows a descriptive-observational, cross-sectional, and prospective design, aiming to delineate the attributes exhibited by patients based on the proposed research variables. The patients in this study had an average age of 61.52, with a Standard Deviation of 18.9. Females constituted the majority, accounting for 53.25% of the participants. Among the comorbidities observed, arterial hypertension was the most prevalent, affecting 19.7% of the patients, followed by Diabetes Mellitus type 2 (DM2) at 9.2%. In this investigation, radiofrequency ablation was found to be present in 36.8% of patients diagnosed with cardiac arrhythmias. The leading cause of cardiac arrhythmia was atrioventricular block, making up 51.3% of cases. Among the implanted devices, the bicameral pacemaker was the most commonly used, accounting for 56.6% of cases, with a risk type of 1.3%. Approximately 42.1% of the patients did not receive any type of pacemaker implantation. The outcome of the procedure was deemed successful in 100% of cases, with minor complications observed in only 1.30% of patients.
